Brief: Clearside Biomedical Announces Q3 2022 Financial Results
09/11/2022 12:40
Nov 9 (Reuters) - Clearside Biomedical Inc CLSD.O :
* CLEARSIDE BIOMEDICAL ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* QTRLY LOSS PER SHARE $0.13
* Q3 EARNINGS PER SHARE VIEW $-0.03 -- REFINITIV IBES DATA
* FAVORABLE SAFETY RESULTS, DURABILITY AND BIOLOGIC EFFECT
OBSERVED IN COHORTS 3 AND 4 OF CLS-AX OASIS PHASE 1/2A TRIAL
Source text for Eikon: ID:nGNX8Tjk15
Further company coverage: CLSD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials